EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

47 reported adverse events

Drug classes: Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

These side effects are most commonly reported by patients taking EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE:

# Side effect Count
0 ANAEMIA 7
1 MATERNAL EXPOSURE DURING PREGNANCY 6
2 NEUTROPENIA 6
3 KAPOSI^S SARCOMA 4
4 DEATH 3
5 RENAL FAILURE 3
6 VOMITING 3
7 ABNORMAL DREAMS 2
8 ABORTION SPONTANEOUS 2
9 ACUTE KIDNEY INJURY 2
See all common reactions for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE

EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 WOLF-HIRSCHHORN SYNDROME 1 0.1000
1 CONFUSIONAL AROUSAL 1 0.0062
2 POST PROCEDURAL HYPOTHYROIDISM 1 0.0047
3 CHRONIC RESPIRATORY DISEASE 1 0.0028
4 WRONG DRUG 1 0.0026
5 DEGENERATIVE BONE DISEASE 1 0.0023
6 MALARIA 1 0.0014
7 HIV INFECTION 2 0.0007
8 MOUTH INJURY 1 0.0007
9 BACTERIAL SEPSIS 2 0.0006
See all enriched reactions for EFAVIRENZ, EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE